Skip to content

Research protocol for the rapid pre - flushing method of HA330 hemoperfusion device in the treatment of acute poisoning

Research protocol for the rapid pre - flushing method of HA330 hemoperfusion device in the treatment of acute poisoning

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120400
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute poisoning

Interventions

Sponsors

West China Fourth Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who, according to the doctor's diagnosis and medical advice, need to be treated with HA330 hemoperfusion device for isolated hemoperfusion 2. Voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: Patients with a history of coagulation disorders and bleeding tendencies.

Design outcomes

Primary

MeasureTime frame
Coagulation laboratory test results;

Secondary

MeasureTime frame
Number of cases of unplanned machine disconnection due to blood coagulation;Pre - flushing duration;

Countries

China

Contacts

Public ContactDai Kaili

West China Fourth Hospital of Sichuan University

1282032860@qq.com+86 85501067

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026